A Clinical Study to Evaluate the Efficacy and Safety of MIN-102 (IMP) in Male AMN Patients.

Kennedy Krieger Institute, Baltimore

Stanford University Medical Center, Stanford

Massachusetts General Hospital, Boston

Hospital de la Pitié-Salpêtrière, Paris

Universitat Leipzig Klinik and Poliklinik für Neurologie, Leipzig

Institute of Genomic Medicine and Rare Disorders, Budapest

Instituto Neurologico Carlo Besta, Milan

Academish Medisch Centrum, Amsterdam

Hospital Universitari Vall d'Hebrón, Barcelona

National hospital for Neurology and Neurosurgery Charles Dent Metabolic Unit), London